Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

YM-68128: orally active double prodrug of a potent antiplatelet agent

Dec. 1, 1999

Anticoagulant, antithrombotic compounds with heterocyclic structure

Nov. 30, 1999

Novel fibrinolytics recently patented by ADIR

Nov. 29, 1999

MonteGen offers potent antithrombotic agent for licensing

Nov. 29, 1999

Pharmacokinetics of EMD-132338 following oral administration of gantofiban

Nov. 25, 1999

FDA approves Aggrenox for prevention of recurrent stroke

Nov. 24, 1999

Anticoagulant serine protease inhibitors described by 3-D

Nov. 24, 1999

Preclinical data presented at AHA support promising profile of V-20

Nov. 17, 1999

Vapreotide superior to placebo in early treatment of portal hypertensive bleeding

Nov. 15, 1999

Integrin alphavbeta3 antagonist findings presented by Genentech team at AHA

Nov. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...